Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Identification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach.
Helicobacter pylori infection reduces disease severity in an experimental model of multiple sclerosis.
Neuromyelitis optica spectrum disorders: beyond longitudinally extensive transverse myelitis.
Aptamer Oligonucleotides: Novel Potential Therapeutic Agents in Autoimmune Disease.
Bone mineral density and body composition in men with multiple sclerosis chronically treated with low-dose glucocorticoids.
Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.
Role of TRIF Small Interference RNA (siRNA) in Chronic Experimental Allergic Encephalomyelitis (EAE).
No evidence of a link between multiple sclerosis and the vaccine against the human papillomavirus.
Patient taking Novartis MS pill developed rare disease
New and emerging immune-targeted drugs for the treatment of multiple sclerosis.
[Biomarkers in multiple sclerosis (a review and experimental data)].
Learning and cognitive fatigue trajectories in multiple sclerosis defined using a burst measurement design.
Two-photon imaging of immune cells in neural tissue.
Multiple Sclerosis (MS) as a demyelinating disease: a review on neurosurgical approaches.
Poly(ADP-ribose) polymerase 2 contributes to neuroinflammation and neurological dysfunction in mouse experimental autoimmune encephalomyelitis.
Verbal fluency deficits in clinically isolated syndrome suggestive of multiple sclerosis.
Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?
Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2.
Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.
Development of Gene Transfer for Induction of Antigen-specific Tolerance.
MS risk allele rs1883832T is associated with decreased mRNA expression of CD40.
The Perspectives of Iranian Patients With Multiple Sclerosis on Continuity of Care: A Qualitative Study.
Identification of cortical lesions using DIR and FLAIR in early stages of multiple sclerosis.
Science to practice: myeloperoxidase immunoradiology improves detection of acute and chronic experimental multiple sclerosis.
HLA associations in South Asian multiple sclerosis.
Pages
« first
‹ previous
…
408
409
410
411
412
413
414
415
416
…
next ›
last »